Home Office consults on medicinal use of cannabis

Home Office consults on medicinal use of cannabis

June 22 2018 A review into the scheduling of cannabis for medicinal purposes will look for...

Measles outbreaks prompt reminder about MMR vaccination ahead of summer holidays

Measles outbreaks prompt reminder about MMR vaccination ahead of summer holidays

June 22 2018 Young people should ensure they have had both doses of the MMR vaccine, especially...

Smoking levels remain unchanged in Wales at 19%

Smoking levels remain unchanged in Wales at 19%

June 22 2018 A downward trend in the proportion of adults smoking has stalled at 19%, the annual...

GP services get 86% satisfaction rating in Wales

GP services get 86% satisfaction rating in Wales

June 20 2018 The percentage of people reporting they were satisfied with their GP services in...

NICE guideline says people with dementia should be involved in discussions about their care

NICE guideline says people with dementia should be involved in discussions about their care

June 20 2018 An updated NICE guideline has recommended that people with dementia should be...

  • Home Office consults on medicinal use of cannabis

    Home Office consults on medicinal use of cannabis

    Friday, 22 June 2018 16:15
  • Measles outbreaks prompt reminder about MMR vaccination ahead of summer holidays

    Measles outbreaks prompt reminder about MMR vaccination ahead of summer holidays

    Friday, 22 June 2018 15:46
  • Smoking levels remain unchanged in Wales at 19%

    Smoking levels remain unchanged in Wales at 19%

    Friday, 22 June 2018 15:40
  • GP services get 86% satisfaction rating in Wales

    GP services get 86% satisfaction rating in Wales

    Wednesday, 20 June 2018 18:50
  • NICE guideline says people with dementia should be involved in discussions about their care

    NICE guideline says people with dementia should be involved in discussions about their care

    Wednesday, 20 June 2018 18:47

a alert imageApril 20 2018

A Class 4 medicines defect alert has been issued relating to Inhixa (enoxaparin sodium) solution for injection, made by Techdow Europe AB.

The medicines regulator, the MHRA, has issued the ‘caution in use’ alert following reports of “rare cases of premature self-activation of the safety device in unused, unopened pre-filled Inhixa syringes.”

The alert lists the following strengths of Inhixa:

  • 2,000 IU (20 mg) in 0.2 mL;
  • 4,000 IU (40 mg) in 0.4 mL;
  • 6,000 IU (60 mg) in 0.6 mL;
  • 8,000 IU (80 mg) in 0.8 mL;
  • 10,000 IU (100 mg) in 1.0 mL.

Pharmacy and GP dispensing practice staff have been asked to visually check all Inhixa syringes (without opening the syringe blister) before dispensing. This is illustrated on the Direct Healthcare Professional Communication (DHCP). 

Further information is available from Techdow Pharma England Ltd on 01271 334 609.

Link:
MHRA statement          
Techdow Direct Healthcare Professional Communication             

Professional News

June 22 2018 A review into the scheduling of cannabis for medicinal purposes will look for “significant medical and therapeutic benefits” before a decision is made.
June 6 2018 The Royal College of General Practitioners has called for visa regulations to be reviewed to allow more doctors to work as GPs in the NHS. Home Secretary Sajit Javid announced on Sunday...